Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

Press releases published on April 27, 2026

Apr. 27, 2026

Umoja Biopharma Announces Unveiling of UB-VV500 in Upcoming Poster Presentation at the American Society of Gene & Cell Therapy Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Rgenta Therapeutics Announces Two Oral Presentations Highlighting Proprietary RSwitch Technology at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Addition Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Beta Bionics to Present at the Bank of America Securities Health Care Conference

Indeterminate GlobeNewswire

Apr. 27, 2026

Oruka Therapeutics Announces Proposed $500 Million Underwritten Public Offering

Indeterminate GlobeNewswire

Apr. 27, 2026

InspireMD to Announce First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Apr. 27, 2026

Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions

Indeterminate GlobeNewswire

Apr. 27, 2026

The Joint Corp. Signs Asset Purchase Agreement to Sell 45 Corporate-Owned Clinics in Southern California

Indeterminate GlobeNewswire

Apr. 27, 2026

Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

TOMI Environmental Positioned for Accelerated Growth as Robotaxi Market Rapidly Expands

Indeterminate GlobeNewswire

Apr. 27, 2026

Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production

Indeterminate GlobeNewswire

Apr. 27, 2026

Erasca Announces Positive Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors

Indeterminate GlobeNewswire

Apr. 27, 2026

Intellia Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire

Apr. 27, 2026

Aegis Treatment Centers Opens Medication Unit in Crescent City, Expanding Access to Addiction Treatment in Del Norte County

Indeterminate GlobeNewswire

Apr. 27, 2026

AI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive Innovation

Indeterminate GlobeNewswire

Apr. 27, 2026

Global Virus Network Statement on H5N1 Vaccine Developments

Indeterminate GlobeNewswire

Apr. 27, 2026

8 Ways to Help Protect Your Vision Right Now

Indeterminate GlobeNewswire